Idorsia forms research collaboration with Roche in the field of cancer immunotherapy – Nasdaq
|
Idorsia forms research collaboration with Roche in the field of cancer immunotherapy
Nasdaq Allschwil, Switzerland – 20 December 2017 – Idorsia Ltd (SIX:IDIA) today announced that it has entered into a research collaboration that provides Roche with an exclusive option right to develop and market first-in-class compounds for a promising new … |
